{
    "table_name": "CPTAC.QUANT_PHOSPHOPROTEOME_AML_GILTERITINIB_TIMECOURSE_PDC_CURRENT",
    "table_fullname": "CPTAC_PDC.CPTAC.QUANT_PHOSPHOPROTEOME_AML_GILTERITINIB_TIMECOURSE_PDC_CURRENT",
    "column_names": [
        "case_id",
        "protein_abundance_log2ratio",
        "aliquot_id",
        "aliquot_run_metadata_id",
        "sample_id",
        "aliquot_submitter_id",
        "phosphorylation_sites",
        "study_name",
        "refseq_id"
    ],
    "column_types": [
        "TEXT",
        "FLOAT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT"
    ],
    "description": [
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null
    ],
    "sample_rows": [
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "1c1f661c-e8d8-44f0-971b-863c32c9ef59",
            "aliquot_id": "2e2c8318-db8c-4131-aaa4-72a8dbfdb229",
            "aliquot_submitter_id": "PTRC_Ex8_P1",
            "aliquot_run_metadata_id": "a44d66b4-e0bf-4c65-afa0-e90f5ef0c6ff",
            "study_name": "AML Gilteritinib TimeCourse -  Phosphoproteome",
            "protein_abundance_log2ratio": -0.2676,
            "refseq_id": "NP_001005271.2",
            "phosphorylation_sites": "s132s138"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "1c1f661c-e8d8-44f0-971b-863c32c9ef59",
            "aliquot_id": "2e2c8318-db8c-4131-aaa4-72a8dbfdb229",
            "aliquot_submitter_id": "PTRC_Ex8_P1",
            "aliquot_run_metadata_id": "a44d66b4-e0bf-4c65-afa0-e90f5ef0c6ff",
            "study_name": "AML Gilteritinib TimeCourse -  Phosphoproteome",
            "protein_abundance_log2ratio": -0.9234,
            "refseq_id": "NP_001005751.1",
            "phosphorylation_sites": "s802"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "1c1f661c-e8d8-44f0-971b-863c32c9ef59",
            "aliquot_id": "2e2c8318-db8c-4131-aaa4-72a8dbfdb229",
            "aliquot_submitter_id": "PTRC_Ex8_P1",
            "aliquot_run_metadata_id": "a44d66b4-e0bf-4c65-afa0-e90f5ef0c6ff",
            "study_name": "AML Gilteritinib TimeCourse -  Phosphoproteome",
            "protein_abundance_log2ratio": -0.6489,
            "refseq_id": "NP_001012339.2",
            "phosphorylation_sites": "s15"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "1c1f661c-e8d8-44f0-971b-863c32c9ef59",
            "aliquot_id": "2e2c8318-db8c-4131-aaa4-72a8dbfdb229",
            "aliquot_submitter_id": "PTRC_Ex8_P1",
            "aliquot_run_metadata_id": "a44d66b4-e0bf-4c65-afa0-e90f5ef0c6ff",
            "study_name": "AML Gilteritinib TimeCourse -  Phosphoproteome",
            "protein_abundance_log2ratio": -0.0088,
            "refseq_id": "NP_001032242.1",
            "phosphorylation_sites": "s213s223"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "1c1f661c-e8d8-44f0-971b-863c32c9ef59",
            "aliquot_id": "2e2c8318-db8c-4131-aaa4-72a8dbfdb229",
            "aliquot_submitter_id": "PTRC_Ex8_P1",
            "aliquot_run_metadata_id": "a44d66b4-e0bf-4c65-afa0-e90f5ef0c6ff",
            "study_name": "AML Gilteritinib TimeCourse -  Phosphoproteome",
            "protein_abundance_log2ratio": 0.2728,
            "refseq_id": "NP_001041631.1",
            "phosphorylation_sites": "s753"
        }
    ]
}